nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemfibrozil—SLCO1B1—Rifampicin—leprosy	0.192	0.217	CbGbCtD
Gemfibrozil—CYP2C8—Rifampicin—leprosy	0.0811	0.0918	CbGbCtD
Gemfibrozil—CYP2C19—Thalidomide—leprosy	0.0702	0.0795	CbGbCtD
Gemfibrozil—CYP2C19—Rifampicin—leprosy	0.068	0.077	CbGbCtD
Gemfibrozil—CYP2C8—Dapsone—leprosy	0.0669	0.0758	CbGbCtD
Gemfibrozil—CYP1A2—Thalidomide—leprosy	0.0648	0.0734	CbGbCtD
Gemfibrozil—CYP1A2—Rifampicin—leprosy	0.0628	0.0711	CbGbCtD
Gemfibrozil—CYP2C9—Thalidomide—leprosy	0.0584	0.0661	CbGbCtD
Gemfibrozil—CYP2C9—Rifampicin—leprosy	0.0565	0.064	CbGbCtD
Gemfibrozil—CYP2C19—Dapsone—leprosy	0.0561	0.0636	CbGbCtD
Gemfibrozil—CYP2C9—Dapsone—leprosy	0.0467	0.0529	CbGbCtD
Gemfibrozil—CYP3A4—Rifampicin—leprosy	0.0329	0.0372	CbGbCtD
Gemfibrozil—CYP3A4—Dapsone—leprosy	0.0271	0.0307	CbGbCtD
Gemfibrozil—Infertility male—Dapsone—leprosy	0.026	0.222	CcSEcCtD
Gemfibrozil—Lupus-like syndrome—Dapsone—leprosy	0.0127	0.109	CcSEcCtD
Gemfibrozil—Peripheral vascular disorder—Thalidomide—leprosy	0.00312	0.0267	CcSEcCtD
Gemfibrozil—Myasthenia—Thalidomide—leprosy	0.00244	0.0208	CcSEcCtD
Gemfibrozil—Neuritis—Thalidomide—leprosy	0.00205	0.0175	CcSEcCtD
Gemfibrozil—Hyperaesthesia—Thalidomide—leprosy	0.00195	0.0167	CcSEcCtD
Gemfibrozil—Nasopharyngitis—Dapsone—leprosy	0.00194	0.0166	CcSEcCtD
Gemfibrozil—Muscular weakness—Dapsone—leprosy	0.00192	0.0164	CcSEcCtD
Gemfibrozil—Pancreatitis—Dapsone—leprosy	0.00184	0.0157	CcSEcCtD
Gemfibrozil—Jaundice cholestatic—Thalidomide—leprosy	0.00174	0.0149	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Dapsone—leprosy	0.00171	0.0146	CcSEcCtD
Gemfibrozil—Drug interaction—Thalidomide—leprosy	0.00165	0.0141	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Dapsone—leprosy	0.00164	0.014	CcSEcCtD
Gemfibrozil—Phosphatase alkaline increased—Thalidomide—leprosy	0.00153	0.0131	CcSEcCtD
Gemfibrozil—Colitis—Thalidomide—leprosy	0.00147	0.0126	CcSEcCtD
Gemfibrozil—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.00128	0.0109	CcSEcCtD
Gemfibrozil—Photosensitivity—Thalidomide—leprosy	0.00127	0.0108	CcSEcCtD
Gemfibrozil—Eczema—Thalidomide—leprosy	0.00124	0.0106	CcSEcCtD
Gemfibrozil—Vision blurred—Dapsone—leprosy	0.00123	0.0105	CcSEcCtD
Gemfibrozil—Libido decreased—Thalidomide—leprosy	0.0012	0.0102	CcSEcCtD
Gemfibrozil—Dermatitis exfoliative—Thalidomide—leprosy	0.00118	0.0101	CcSEcCtD
Gemfibrozil—Vertigo—Dapsone—leprosy	0.00118	0.01	CcSEcCtD
Gemfibrozil—Atrial fibrillation—Thalidomide—leprosy	0.00117	0.01	CcSEcCtD
Gemfibrozil—Cough—Dapsone—leprosy	0.00114	0.00975	CcSEcCtD
Gemfibrozil—Disturbance in sexual arousal—Thalidomide—leprosy	0.0011	0.00943	CcSEcCtD
Gemfibrozil—Liver function test abnormal—Thalidomide—leprosy	0.00103	0.00877	CcSEcCtD
Gemfibrozil—Breast disorder—Thalidomide—leprosy	0.001	0.00859	CcSEcCtD
Gemfibrozil—Muscular weakness—Thalidomide—leprosy	0.000981	0.00838	CcSEcCtD
Gemfibrozil—Eosinophilia—Thalidomide—leprosy	0.000952	0.00813	CcSEcCtD
Gemfibrozil—Pancreatitis—Thalidomide—leprosy	0.000942	0.00805	CcSEcCtD
Gemfibrozil—Pancytopenia—Thalidomide—leprosy	0.000913	0.0078	CcSEcCtD
Gemfibrozil—Erectile dysfunction—Thalidomide—leprosy	0.000885	0.00756	CcSEcCtD
Gemfibrozil—Photosensitivity reaction—Thalidomide—leprosy	0.000877	0.0075	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Dapsone—leprosy	0.000873	0.00746	CcSEcCtD
Gemfibrozil—Weight decreased—Thalidomide—leprosy	0.00087	0.00743	CcSEcCtD
Gemfibrozil—Depression—Thalidomide—leprosy	0.000854	0.0073	CcSEcCtD
Gemfibrozil—Abdominal pain—Dapsone—leprosy	0.000844	0.00721	CcSEcCtD
Gemfibrozil—Renal failure—Thalidomide—leprosy	0.000842	0.0072	CcSEcCtD
Gemfibrozil—Neuropathy peripheral—Thalidomide—leprosy	0.00084	0.00718	CcSEcCtD
Gemfibrozil—Rhinitis—Thalidomide—leprosy	0.000771	0.00659	CcSEcCtD
Gemfibrozil—Hypoaesthesia—Thalidomide—leprosy	0.000765	0.00654	CcSEcCtD
Gemfibrozil—Eye disorder—Thalidomide—leprosy	0.000719	0.00614	CcSEcCtD
Gemfibrozil—Mediastinal disorder—Thalidomide—leprosy	0.000693	0.00592	CcSEcCtD
Gemfibrozil—Alopecia—Thalidomide—leprosy	0.00068	0.00581	CcSEcCtD
Gemfibrozil—Vomiting—Dapsone—leprosy	0.000679	0.0058	CcSEcCtD
Gemfibrozil—Mental disorder—Thalidomide—leprosy	0.000674	0.00576	CcSEcCtD
Gemfibrozil—Headache—Dapsone—leprosy	0.000669	0.00572	CcSEcCtD
Gemfibrozil—Flatulence—Thalidomide—leprosy	0.00066	0.00564	CcSEcCtD
Gemfibrozil—Tension—Thalidomide—leprosy	0.000657	0.00562	CcSEcCtD
Gemfibrozil—Dysgeusia—Thalidomide—leprosy	0.000656	0.0056	CcSEcCtD
Gemfibrozil—Nervousness—Thalidomide—leprosy	0.00065	0.00556	CcSEcCtD
Gemfibrozil—Nausea—Dapsone—leprosy	0.000634	0.00542	CcSEcCtD
Gemfibrozil—Vision blurred—Thalidomide—leprosy	0.000631	0.00539	CcSEcCtD
Gemfibrozil—Anaemia—Thalidomide—leprosy	0.000619	0.00529	CcSEcCtD
Gemfibrozil—Angioedema—Thalidomide—leprosy	0.000612	0.00523	CcSEcCtD
Gemfibrozil—Vertigo—Thalidomide—leprosy	0.000602	0.00514	CcSEcCtD
Gemfibrozil—Syncope—Thalidomide—leprosy	0.000601	0.00513	CcSEcCtD
Gemfibrozil—Leukopenia—Thalidomide—leprosy	0.000599	0.00512	CcSEcCtD
Gemfibrozil—Loss of consciousness—Thalidomide—leprosy	0.000589	0.00503	CcSEcCtD
Gemfibrozil—Cough—Thalidomide—leprosy	0.000584	0.00499	CcSEcCtD
Gemfibrozil—Convulsion—Thalidomide—leprosy	0.00058	0.00496	CcSEcCtD
Gemfibrozil—Chest pain—Thalidomide—leprosy	0.00057	0.00487	CcSEcCtD
Gemfibrozil—Myalgia—Thalidomide—leprosy	0.00057	0.00487	CcSEcCtD
Gemfibrozil—Arthralgia—Thalidomide—leprosy	0.00057	0.00487	CcSEcCtD
Gemfibrozil—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000566	0.00484	CcSEcCtD
Gemfibrozil—Confusional state—Thalidomide—leprosy	0.000551	0.00471	CcSEcCtD
Gemfibrozil—Oedema—Thalidomide—leprosy	0.000547	0.00467	CcSEcCtD
Gemfibrozil—Shock—Thalidomide—leprosy	0.000538	0.0046	CcSEcCtD
Gemfibrozil—Nervous system disorder—Thalidomide—leprosy	0.000536	0.00458	CcSEcCtD
Gemfibrozil—Thrombocytopenia—Thalidomide—leprosy	0.000535	0.00457	CcSEcCtD
Gemfibrozil—Skin disorder—Thalidomide—leprosy	0.000531	0.00454	CcSEcCtD
Gemfibrozil—Musculoskeletal discomfort—Thalidomide—leprosy	0.000498	0.00426	CcSEcCtD
Gemfibrozil—Paraesthesia—Thalidomide—leprosy	0.000491	0.00419	CcSEcCtD
Gemfibrozil—Somnolence—Thalidomide—leprosy	0.000486	0.00415	CcSEcCtD
Gemfibrozil—Dyspepsia—Thalidomide—leprosy	0.000481	0.00411	CcSEcCtD
Gemfibrozil—Gastrointestinal disorder—Thalidomide—leprosy	0.000472	0.00403	CcSEcCtD
Gemfibrozil—Fatigue—Thalidomide—leprosy	0.000471	0.00403	CcSEcCtD
Gemfibrozil—Constipation—Thalidomide—leprosy	0.000467	0.00399	CcSEcCtD
Gemfibrozil—Pain—Thalidomide—leprosy	0.000467	0.00399	CcSEcCtD
Gemfibrozil—Feeling abnormal—Thalidomide—leprosy	0.00045	0.00385	CcSEcCtD
Gemfibrozil—Gastrointestinal pain—Thalidomide—leprosy	0.000447	0.00382	CcSEcCtD
Gemfibrozil—Urticaria—Thalidomide—leprosy	0.000434	0.00371	CcSEcCtD
Gemfibrozil—Abdominal pain—Thalidomide—leprosy	0.000432	0.00369	CcSEcCtD
Gemfibrozil—Asthenia—Thalidomide—leprosy	0.000392	0.00335	CcSEcCtD
Gemfibrozil—Pruritus—Thalidomide—leprosy	0.000387	0.0033	CcSEcCtD
Gemfibrozil—Diarrhoea—Thalidomide—leprosy	0.000374	0.0032	CcSEcCtD
Gemfibrozil—Dizziness—Thalidomide—leprosy	0.000361	0.00309	CcSEcCtD
Gemfibrozil—Vomiting—Thalidomide—leprosy	0.000348	0.00297	CcSEcCtD
Gemfibrozil—Rash—Thalidomide—leprosy	0.000345	0.00294	CcSEcCtD
Gemfibrozil—Dermatitis—Thalidomide—leprosy	0.000344	0.00294	CcSEcCtD
Gemfibrozil—Headache—Thalidomide—leprosy	0.000342	0.00293	CcSEcCtD
Gemfibrozil—Nausea—Thalidomide—leprosy	0.000325	0.00277	CcSEcCtD
